Switch theme
Sign up to access all valuation multiples
BICO Group AB is a bio-convergence company. The company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Group consists of three reporting segments: Bioprinting, Life Science Solutions, and Lab Automation. Bioprinting consists of CELLINK, MatTek, Visikol, and Advanced BioMatrix. Life Science Solutions consists of CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, and Cellenion. Lab Automation consists of Biosero.
2000
726
LTM Revenue $199M
LTM EBITDA $16.2M
$345M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
BICO Group has a last 12-month revenue (LTM) of $199M and a last 12-month EBITDA of $16.2M.
In the most recent fiscal year, BICO Group achieved revenue of $201M and an EBITDA of $52.1M.
BICO Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See BICO Group valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $199M | XXX | $201M | XXX | XXX | XXX |
| Gross Profit | $100M | XXX | $104M | XXX | XXX | XXX |
| Gross Margin | 50% | XXX | 52% | XXX | XXX | XXX |
| EBITDA | $16.2M | XXX | $52.1M | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 26% | XXX | XXX | XXX |
| EBIT | -$22.7M | XXX | -$31.2M | XXX | XXX | XXX |
| EBIT Margin | -11% | XXX | -16% | XXX | XXX | XXX |
| Net Profit | -$16.7M | XXX | -$0.6M | XXX | XXX | XXX |
| Net Margin | -8% | XXX | 0% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $76.9M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, BICO Group's stock price is SEK 36 (or $4).
BICO Group has current market cap of SEK 2.5B (or $262M), and EV of SEK 3.3B (or $345M).
See BICO Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $345M | $262M | XXX | XXX | XXX | XXX | $-0.24 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, BICO Group has market cap of $262M and EV of $345M.
BICO Group's trades at 1.7x EV/Revenue multiple, and 6.6x EV/EBITDA.
Equity research analysts estimate BICO Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
BICO Group has a P/E ratio of -15.6x.
See valuation multiples for BICO Group and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $262M | XXX | $262M | XXX | XXX | XXX |
| EV (current) | $345M | XXX | $345M | XXX | XXX | XXX |
| EV/Revenue | 1.7x | XXX | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | 21.3x | XXX | 6.6x | XXX | XXX | XXX |
| EV/EBIT | -15.2x | XXX | -11.1x | XXX | XXX | XXX |
| EV/Gross Profit | 3.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | -15.6x | XXX | -461.2x | XXX | XXX | XXX |
| EV/FCF | 17.7x | XXX | 46.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialBICO Group's last 12 month revenue growth is 0%
BICO Group's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
BICO Group's rule of 40 is 15% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
BICO Group's rule of X is 7% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for BICO Group and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 0% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 26% | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | -35% | XXX | XXX | XXX |
| Rule of 40 | 15% | XXX | 26% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 7% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 22% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 18% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 67% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
BICO Group acquired XXX companies to date.
Last acquisition by BICO Group was XXXXXXXX, XXXXX XXXXX XXXXXX . BICO Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was BICO Group founded? | BICO Group was founded in 2000. |
| Where is BICO Group headquartered? | BICO Group is headquartered in Sweden. |
| How many employees does BICO Group have? | As of today, BICO Group has 726 employees. |
| Who is the CEO of BICO Group? | BICO Group's CEO is Ms. Maria Forss. |
| Is BICO Group publicy listed? | Yes, BICO Group is a public company listed on STO. |
| What is the stock symbol of BICO Group? | BICO Group trades under BICO ticker. |
| When did BICO Group go public? | BICO Group went public in 2016. |
| Who are competitors of BICO Group? | Similar companies to BICO Group include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of BICO Group? | BICO Group's current market cap is $262M |
| What is the current revenue of BICO Group? | BICO Group's last 12 months revenue is $199M. |
| What is the current revenue growth of BICO Group? | BICO Group revenue growth (NTM/LTM) is 0%. |
| What is the current EV/Revenue multiple of BICO Group? | Current revenue multiple of BICO Group is 1.7x. |
| Is BICO Group profitable? | Yes, BICO Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of BICO Group? | BICO Group's last 12 months EBITDA is $16.2M. |
| What is BICO Group's EBITDA margin? | BICO Group's last 12 months EBITDA margin is 8%. |
| What is the current EV/EBITDA multiple of BICO Group? | Current EBITDA multiple of BICO Group is 21.3x. |
| What is the current FCF of BICO Group? | BICO Group's last 12 months FCF is $19.5M. |
| What is BICO Group's FCF margin? | BICO Group's last 12 months FCF margin is 10%. |
| What is the current EV/FCF multiple of BICO Group? | Current FCF multiple of BICO Group is 17.7x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
